sylabs singularity
productUScpe:2.3:a:sylabs:singularity:*:*:*:*:*:*:*:*
A product tracked in the threat graph; the vulnerabilities below are known to affect it.
0
KEV-listed
0
public exploit
0
EPSS ≥ 10%
by severity
3critical9high3medium0low
updated 2026-10-28
01
vulnerabilities (15)
Related CVEs.
| ID | severity | exploitable |
|---|---|---|
| CVE-2019-11328US | high8.8 | — |
| CVE-2020-15229US | critical9.3 | — |
| CVE-2020-25040US | high8.8 | — |
| CVE-2020-25039US | high8.1 | — |
| CVE-2018-12021US | medium6.5 | — |
| CVE-2021-32635US | medium6.3 | — |
| CVE-2020-13846US | high7.5 | — |
| CVE-2021-33027US | critical9.8 | — |
| CVE-2021-33622US | critical9.8 | — |
| CVE-2019-19724US | high7.5OT elevated | — |
| CVE-2020-13847US | high7.5 | — |
| CVE-2020-13845US | high7.5 | — |
| CVE-2018-19295US | high7.8 | — |
| CVE-2023-30549US | high7.8 | — |
| CVE-2021-29136US | medium5.5 | — |
02
weaknesses (8)
The flaw types (CWEs) most of these CVEs share.
- CWE-20Improper Input Validation3 CVEs
- CWE-732Incorrect Permission Assignment for Critical Resource3 CVEs
- CWE-354Improper Validation of Integrity Check Value2 CVEs
- CWE-668Exposure of Resource to Wrong Sphere2 CVEs
- CWE-200Exposure of Sensitive Information to an Unauthorized Actor1 CVEs
- CWE-203Observable Discrepancy1 CVEs
- CWE-22Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')1 CVEs
- CWE-269Improper Privilege Management1 CVEs
03
sources (1)
Which sources assert this record, and when.
- USNVD / CVE15 CVEs
scry
Products carry known vulnerabilities once they are exposed to the internet. See what is exposed on your perimeter with a free passive scan.
Free scan